Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Appian Corp (APPN) vs Sanofi SA (SNY) Price & Performance

Appian CorpTrade

Price performance (Past 24H)

Key statistics

Appian Corp vs Sanofi SA — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 41.1× Appian Corp's market cap, and Sanofi SA pays a 5.55% dividend while Appian Corp pays none. Which is the better fit depends on your goals.

APPNSNY
Market Cap
$2.54B$104.30B
Sector
TechnologyHealth
52-Week High
$45.64$52.34
52-Week Low
$18.72$41.33
Enterprise Value
$2.67B$124.19B
Dividend Yield
5.55%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Appian Corp

Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.

Read more on APPN

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY